Image
Pfizer Court Fight Could Legalize Medicare Copays And Unleash ‘Gold Rush’ in Sales
A Pfizer win in a lawsuit against the federal government could cost taxpayers billions of dollars and erase an important control on pharma marketing after decades of regulatory erosion and soaring drug prices, say health policy analysts.
Jul 29, 2021